ZYME

ZymeworksD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-21

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

ZYME vs peer average

39/100

ZYME vs. peer average (D vs. C)

Grade spread

A 1 · C 5 · D 3 · F 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

MGNX is the first available peer comparator.

MacroGenics — bispecific and antibody platform peer with similar clinical/regulatory execution risk.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerMGNXMacroGenics

ZYME

Zymeworks

MGNX

MacroGenics

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs MGNX

ZYME / MGNX

Grade Position

Below peers

ZYME vs. peer average (D vs. C)

39/100

Momentum

MGNX

Value

ZYME

Sentiment

ZYME

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs ZYME

MGNX

60/100

-1

REGN

60/100

-1

IMCR

Immunocore Holdings Plc American ADR

40/100

Even

AAPG

Ascentage Pharma Group International ADR Unsp

20/100

STOK

Stoke Therapeutics Inc Common

40/100

Even

MGNX is the first peer returned for this comparison set.